Tinglong Dai

Dr. Tinglong Dai

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Manufacturing & Service Operations Management
Verified
Journal Article
Closed access
YCYing-Ju Chen
Ying-Ju Chen
TDTinglong Dai
Tinglong Dai
CKC. Gizem Korpeoglu
C. Gizem Korpeoglu
EKErsin Körpeoğlu
Ersin Körpeoğlu
OSOzge Sahin
Ozge Sahin
SXShihong Xiao
Shihong Xiao
Economic growth in many countries is increasingly driven by successful startups that operate as online platforms. These success stories have motivated us to define and classify various online platforms according to their business models. This study discusses strategic and operational issues arising from five types of online platforms (resource sharing, matching, crowdsourcing, review, and crowdfunding) and presents some research opportunities for operations management scholars to explore.

1 September 2020 in Manufacturing & Service Operations Management
Verified
Journal Article
Closed access
TDTinglong Dai
Tinglong Dai
STSridhar Tayur
Sridhar Tayur
A new generation of healthcare operations management (HOM) scholars is studying timely healthcare topics (e.g., organization design, design of delivery, and organ transplantation) using contemporary methodological tools (e.g., econometrics, information economics, and queuing games). A distinguishing feature of this stream of work is that it explicitly incorporates behavior, incentive, and policy considerations arising from the entanglements across multiple entities that make up the complex healthcare ecosystem. This focus is a departure from an earlier generation of research that primarily centered on optimizing given operations of a single entity. This paper provides an introduction to this burgeoning field and maps out research opportunities. We start with identifying key entities of healthcare delivery, financing, innovation, and policymaking, illustrating them on a healthcare ecosystem map (HEM). Next, we explore the HOM literature examining the interactions among various entities in the HEM. We then develop a taxonomy for the recent HOM literature (published in Manufacturing & Service Operations Management, Management Science, and Operations Research between 2013 and 2017), provide a tool-thrust graph mapping methodological tools with research thrusts, and situate the HOM literature in context by connecting it with perspectives from medical journals and mass media. We close with a reference to technological innovations that have the potential to transform the healthcare ecosystem in future decades.

1 March 2022 in Service Science
Verified
Journal Article
Closed access
TDTinglong Dai
Tinglong Dai
CTChristopher Tang
Christopher Tang
The COVID-19 pandemic has highlighted the instrumental role of supply chains in delivering economic, human, and societal value. At the same time, the pandemic has intensified interest among businesses, governments, and academics to examine environmental, social, and governance (ESG) issues. In today’s hyper-globalized economy, ESG measures are futile unless they explicitly incorporate a firm’s end-to-end operations throughout its entire supply chain. On the other hand, well-calibrated ESG measures should play a central role in guiding a firms’ day-to-day supply chain management practices. To illustrate the value of unifying ESG and end-to-end supply chain thinking, we present three supply chain cases that arose amid the COVID-19 pandemic, involving online platforms; public health supply chains; and vaccine development, manufacturing, and distribution, respectively. Drawn from these three cases, we spotlight some new research opportunities in both ESG and supply chain management.

1 July 2016 in Manufacturing & Service Operations Management
Verified
Journal Article
Closed access
TDTinglong Dai
Tinglong Dai
SCSoo-Haeng Cho
Soo-Haeng Cho
FZFuqiang Zhang
Fuqiang Zhang
Although influenza vaccine shortage is often attributed to low supply, it has been observed that even with abundant supply, a major shortage can still occur because of late delivery. In this paper, motivated by the influenza vaccine industry, we study a supply chain contracting problem in the presence of uncertainties surrounding design, delivery, and demand of the influenza vaccine. In this supply chain, a manufacturer has insufficient incentive to initiate at-risk early production prior to the design freeze because it is a retailer who reaps the most benefits from selling more vaccines delivered on time. Anticipating that late delivery will lead to potential loss in demand, the retailer tends to reduce the order size, which further discourages the manufacturer from making an effort to improve its delivery performance. To break this negative feedback loop, a supply contract needs to achieve two objectives: incentivize at-risk early production and eliminate double marginalization. We find that two commonly observed supply contracts in practice, the delivery-time-dependent quantity flexibility (D-QF) contract and the late-rebate (LR) contract, may fail to coordinate the supply chain because of the tension between these two objectives. To resolve such a tension, we construct a buyback-and-late-rebate (BLR) contract and show that a properly designed BLR contract can not only coordinate the supply chain but also can provide full flexibility of profit division between members of the supply chain. Numerical experiments further demonstrate that the BLR contract significantly improves supply chain efficiency compared to the contracts used in the industry.

1 December 2022 in Production and Operations Management
Verified
Journal Article
Closed access
TDTinglong Dai
Tinglong Dai
STSridhar Tayur
Sridhar Tayur

1 November 2013 in Management Science
Verified
Journal Article
Closed access
TDTinglong Dai
Tinglong Dai
KJKinshuk Jerath
Kinshuk Jerath
We study a scenario in which a firm designs the compensation contract for a salesperson who exerts unobservable effort to increase the level of uncertain demand and, jointly, the firm also decides the inventory level to be stocked. We use a newsvendor-type model in which actual sales depend on the realized demand but are limited by the inventory available, and unfulfilled demand cannot be observed. In this setup, under the optimal contract, the agent is paid a bonus for meeting a sales quota. Our key result is that it may be optimal for the firm to stock more than the first-best inventory level, because this enables the firm to obtain a more precise indicator of the salesperson's effort. The possibility of stockouts due to limited inventory also leads to several counterintuitive results, including the following: (i) relative to when stockouts are not considered, it may be optimal for the firm to pay a higher bonus even though limited inventory constrains sales; (ii) as inventory becomes more expensive, thereby forcing the firm to lower its inventory, the firm may nevertheless pay the agent a higher bonus; and (iii) if there is a lower probability that the agent's effort exertion leads to high demand, rather than lowering inventory due to the lower sales potential, the firm may increase inventory. This paper was accepted by J. Miguel Villas-Boas, marketing.